肺纤维化或始于婴儿期:从儿童到成人的间质性肺疾病
本文综述儿童间质性肺疾病(chILD)中肺纤维化的现状,基于登记数据初步估计多种chILD表现中纤维化的发生情况,共识别47种潜在纤维化的chILD病种。作者指出需提高呼吸科医生对chILD的认识以优化儿科至成人过渡期照护,并呼吁更新循证指南纳入免疫介导疾病及接近成人期chILD的诊疗推荐。
要点
- chILD包含一组罕见异质性呼吸疾病,部分患者纤维化病变可进展至成年。
- 基于登记数据初步估计47种chILD病种具有潜在纤维化可能。
- 需提升呼吸科医生对chILD的认识并更新循证指南以优化过渡期照护。
核心结论
- 儿童间质性肺疾病(chILD)中肺纤维化可延续至成年,其频率、管理和结局尚不明确。
- 需提高呼吸科医生对chILD的认知以优化儿科至成人照护过渡,并更新循证指南。
研究设计与样本
- 综述,评估chILD中肺纤维化的当前认识,基于登记数据初步估计纤维化在各chILD表现中的发生情况。
主要发现
- 识别出47种不同的潜在纤维化chILD病种。
- 近十年chILD病谱因先进基因检测发现新病种而显著扩大,但多数证据限于小型病例系列。
关键数值与推荐
- 47种chILD病种被识别为潜在纤维化。
- 基于登记数据初步估计纤维化在多种chILD表现中的发生情况。
临床怎么用
- 呼吸科医生应提高对chILD的认识,以优化从儿科到成人医疗的过渡期照护。
- 需更新循证指南,纳入免疫介导疾病及接近成人期chILD的诊断和管理推荐。
局限性
- 多数证据限于小型病例系列,且分散于各亚专科、临床和分子期刊。
- paediatric肺纤维化的频率、管理和结局表征不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Childhood interstitial lung disease (chILD) encompasses a group of rare heterogeneous respiratory conditions associated with significant morbidity and mortality. Reports suggest that many patients diagnosed with chILD continue to have potentially progressive or fibrosing disease into adulthood. Over the last decade, the spectrum of conditions within chILD has widened substantially, with the discovery of novel entities through advanced genetic testing. However, most evidence is often limited to small case series, with reports disseminated across an array of subspecialty, clinical and molecular journals. In particular, the frequency, management and outcome of paediatric pulmonary fibrosis is not well characterised, unlike in adults, where clear diagnosis and treatment guidelines are available. METHODS AND RESULTS: This review assesses the current understanding of pulmonary fibrosis in chILD. Based on registry data, we have provisionally estimated the occurrence of fibrosis in various manifestations of chILD, with 47 different potentially fibrotic chILD entities identified. Published evidence for fibrosis in the spectrum of chILD entities is assessed, and current and future issues in management of pulmonary fibrosis in childhood, continuing into adulthood, are considered. CONCLUSIONS: There is a need for improved knowledge of chILD among pulmonologists to optimise the transition of care from paediatric to adult facilities. Updated evidence-based guidelines are needed that incorporate recommendations for the diagnosis and management of immune-mediated disorders, as well as chILD in older children approaching adulthood.
引用
- Griese M, Kurland G, Cidon M, et al. Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease. Thorax. 2024. PMID: 39153860. doi:10.1136/thorax-2024-221772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。